Home
- Naturade Significantly Strengthens Balance Sheet; Receives $2.5 Million in Capital from Westgate Equity Partners, L.P.
- Natrol Appoints Vincent Andrich VP Sales for Prolab Division
- Vermont Pure Holdings, Ltd. Announces Record Fiscal Year 2001 Results
- Body Shop Reports 24.8 Mil Euro Sales Revenues
- Spectrum Organic Products Responds to FDA Letter Regarding Use of Non-GMO Seal on Canola Oil Label
- Supplement Group Targets Consumer Education
- Advanced Nutraceuticals, Inc. Announces 2001 Year End Results And Additional Financing
- ADM Awarded Nutraceuticals Patent Patent Creates Proprietary Position for ADM in Fast-Growing Nutraceutical Market
- Tantivy Sciences Obtains Exclusive License to Unique Nutraceutical Products
- Top GNC Executives Tour Pittsburgh Market to Present New Business Plan and Expansion Possibilities; Meeting will focus on new business strategies and growth
- Nutrition 21 Receives Patent For the Nutritional Treatment of Type 2 Diabetes; Patent Presents New Pharmaceutical Licensing Opportunities
- ConsumerLab.com Finds Most B-vitamin Supplements Contain What They Claim, But Often Exceed Safe Levels - Consumers Cautioned to Be Aware of Side Effects with High Dose Products
- Nutraceutix, Inc., Nutravite Announcement Commercial Availability of CDT™ Glucosamine for Canadian Marketplace
- Harvey Kamil Appointed President of NBTY, Inc. - Scott Rudolph to Continue as Chairman and CEO
- drugstore.com Expects to Reach Profitability Target in 2003
- Human Genome Project Leads to Innovative Healthcare
- NPIcenter’s Career Center targets nutraceutical Industry
- Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders
- Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders
- Editorial: An Exercise in Synergy
- NBTY, Inc. Appoints Harvey Kamil President, Scott Rudolph To Continue As Chairman And CEO
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- LignisulMSM vs Naproxen for Osteoarthritis Clinical Trial Gets Underway
- Natural Health Trends Corp. Launches Lexxus Taiwan
- FDA Presents Compliance Guide for Structure/Function Claims
- New TrimFit® Bars Redefine Energy Bar Category
- New TrimFit® Bars Redefine Energy Bar Category
- Probiata® Offers Safe, Natural and Effective Alternative
- Alive & Well with Michelle Harris
- Be Well and Get Rewarded! Find Personalized Wellness Solutions and Earn Free Vitamins at NatureMade.com
- Consumers Search for Healthy Cleaning Products That Work
- Nordic Naturals: Omega 3 Fatty Acids
- Cyanotech Names Bob Capelli as Director of Sales
- Recent Study Reinforces the Benefits of Omega-3 Fatty Acids For Women
A new study published in the October
2004 issue of Obstetrical & Gynecological Survey, concluded that women in particular gain from an increased intake of omega-3 fatty acids.
- Recent Study Reinforces the Benefits of Omega-3 Fatty Acids For Women
A new study published in the October
2004 issue of Obstetrical & Gynecological Survey, concluded that women in particular gain from an increased intake of omega-3 fatty acids.
- Recent Study Reinforces the Benefits of Omega-3 Fatty Acids For Women
A new study published in the October
2004 issue of Obstetrical & Gynecological Survey, concluded that women in particular gain from an increased intake of omega-3 fatty acids.
- Research Study Says Soy Protein Consumption Can Reduce the Risk of Breast Cancer in Women
Study published in The International Journal of Cancer Prevention Regular consumption of soy protein-containing foods and beverages may reduce the risk of breast cancer in women by as much as 22%.
- Research Study Says Soy Protein Consumption Can Reduce the Risk of Breast Cancer in Women
Study published in The International Journal of Cancer Prevention Regular consumption of soy protein-containing foods and beverages may reduce the risk of breast cancer in women by as much as 22%.
- Research Study Says Soy Protein Consumption Can Reduce the Risk of Breast Cancer in Women
Study published in The International Journal of Cancer Prevention Regular consumption of soy protein-containing foods and beverages may reduce the risk of breast cancer in women by as much as 22%.
- Research Study Says Soy Protein Consumption Can Reduce the Risk of Breast Cancer in Women
Study published in The International Journal of Cancer Prevention Regular consumption of soy protein-containing foods and beverages may reduce the risk of breast cancer in women by as much as 22%.
- Research Study Says Soy Protein Consumption Can Reduce the Risk of Breast Cancer in Women
Study published in The International Journal of Cancer Prevention Regular consumption of soy protein-containing foods and beverages may reduce the risk of breast cancer in women by as much as 22%.
- Research Study Says Soy Protein Consumption Can Reduce the Risk of Breast Cancer in Women
Study published in The International Journal of Cancer Prevention Regular consumption of soy protein-containing foods and beverages may reduce the risk of breast cancer in women by as much as 22%.
- Effects of Flaxseed Intake in Healthy Menopausal Women
- Soy Protein and Quality of Life in Postmenopausal Women
- Largest Trial of Vitamin E Shows Heart Health Benefit For Women
results of a new study involving nearly 40,000 healthy women finds that vitamin E significantly reduced the risk of death from cardiovascular disease; study, published in the July 6 edition of the Journal of the American Medical Association, also confirmed that vitamin E is safe.
- Largest Trial of Vitamin E Shows Heart Health Benefit For Women
results of a new study involving nearly 40,000 healthy women finds that vitamin E significantly reduced the risk of death from cardiovascular disease; study, published in the July 6 edition of the Journal of the American Medical Association, also confirmed that vitamin E is safe.
- Largest Trial of Vitamin E Shows Heart Health Benefit For Women
results of a new study involving nearly 40,000 healthy women finds that vitamin E significantly reduced the risk of death from cardiovascular disease; study, published in the July 6 edition of the Journal of the American Medical Association, also confirmed that vitamin E is safe.
- Largest Trial of Vitamin E Shows Heart Health Benefit For Women
results of a new study involving nearly 40,000 healthy women finds that vitamin E significantly reduced the risk of death from cardiovascular disease; study, published in the July 6 edition of the Journal of the American Medical Association, also confirmed that vitamin E is safe.
- Largest Trial of Vitamin E Shows Heart Health Benefit For Women
results of a new study involving nearly 40,000 healthy women finds that vitamin E significantly reduced the risk of death from cardiovascular disease; study, published in the July 6 edition of the Journal of the American Medical Association, also confirmed that vitamin E is safe.
- Largest Trial of Vitamin E Shows Heart Health Benefit For Women
results of a new study involving nearly 40,000 healthy women finds that vitamin E significantly reduced the risk of death from cardiovascular disease; study, published in the July 6 edition of the Journal of the American Medical Association, also confirmed that vitamin E is safe.
- Effects of Epigallocatechin Gallate (EGCG); from Tea on Nonheme-iron Absorption in Healthy Women with Low Iron Levels
- Kava Shown to Reduce Anxiety in Perimenopausal Women
- Dietary Fat Intake Linked to Dry Eye Syndrome in Women
Study, published in the October 2005 issue of the American Journal of Clinical Nutrition indicates that women with the highest levels of omega 3 in their diets reduced their risk of dry eye syndrome by 20 percent compared to women with the lowest levels of this fat in their diet and that a dietary ratio of omega 6 to omega 3 greater than 15:1 was associated with a 2.5-fold increased risk of dry eye syndrome in women.
- Dietary Fat Intake Linked to Dry Eye Syndrome in Women
Study, published in the October 2005 issue of the American Journal of Clinical Nutrition indicates that women with the highest levels of omega 3 in their diets reduced their risk of dry eye syndrome by 20 percent compared to women with the lowest levels of this fat in their diet and that a dietary ratio of omega 6 to omega 3 greater than 15:1 was associated with a 2.5-fold increased risk of dry eye syndrome in women.
- Dietary Fat Intake Linked to Dry Eye Syndrome in Women
Study, published in the October 2005 issue of the American Journal of Clinical Nutrition indicates that women with the highest levels of omega 3 in their diets reduced their risk of dry eye syndrome by 20 percent compared to women with the lowest levels of this fat in their diet and that a dietary ratio of omega 6 to omega 3 greater than 15:1 was associated with a 2.5-fold increased risk of dry eye syndrome in women.
- Dietary Fat Intake Linked to Dry Eye Syndrome in Women
Study, published in the October 2005 issue of the American Journal of Clinical Nutrition indicates that women with the highest levels of omega 3 in their diets reduced their risk of dry eye syndrome by 20 percent compared to women with the lowest levels of this fat in their diet and that a dietary ratio of omega 6 to omega 3 greater than 15:1 was associated with a 2.5-fold increased risk of dry eye syndrome in women.
- Dietary Fat Intake Linked to Dry Eye Syndrome in Women
Study, published in the October 2005 issue of the American Journal of Clinical Nutrition indicates that women with the highest levels of omega 3 in their diets reduced their risk of dry eye syndrome by 20 percent compared to women with the lowest levels of this fat in their diet and that a dietary ratio of omega 6 to omega 3 greater than 15:1 was associated with a 2.5-fold increased risk of dry eye syndrome in women.
- Vitamin C And E Supplements Do Not Prevent Pre-Eclampsia In Pregnant Women At Risk
Vitamin C and E supplements do not lower the risk of pre-eclampsia in pregnant women with
a high chance of developing the condition, according to the results of a randomised trial published by The Lancet.
- Vitamin C And E Supplements Do Not Prevent Pre-Eclampsia In Pregnant Women At Risk
Vitamin C and E supplements do not lower the risk of pre-eclampsia in pregnant women with
a high chance of developing the condition, according to the results of a randomised trial published by The Lancet.
- Vitamin C And E Supplements Do Not Prevent Pre-Eclampsia In Pregnant Women At Risk
Vitamin C and E supplements do not lower the risk of pre-eclampsia in pregnant women with
a high chance of developing the condition, according to the results of a randomised trial published by The Lancet.
- Postnatal Nutrients Outperform Prenatals for Use in the Postpartum Period of Pregnancy Recovery
Company announces the results of clinical outcomes from a prospective, randomized, double-blind, placebo controlled trial on their postnatal nutrient program After Baby Boost.
- Postnatal Nutrients Outperform Prenatals for Use in the Postpartum Period of Pregnancy Recovery
Company announces the results of clinical outcomes from a prospective, randomized, double-blind, placebo controlled trial on their postnatal nutrient program After Baby Boost.
- Postnatal Nutrients Outperform Prenatals for Use in the Postpartum Period of Pregnancy Recovery
Company announces the results of clinical outcomes from a prospective, randomized, double-blind, placebo controlled trial on their postnatal nutrient program After Baby Boost.
- Menopause Study Shows Remifemin(R) Black Cohosh Is Safer Than HRT
A new safety study by Hirschberg, et al., on Remifemin(R) black cohosh extract, published in Menopause: The Journal of The North American Menopause Society, suggest that suggest that Remifemin(R) black cohosh does not cause adverse effects on breast tissue, and, the data do not indicate any endometrial or general safety concerns during 6 months of treatment.
- Menopause Study Shows Remifemin(R) Black Cohosh Is Safer Than HRT
A new safety study by Hirschberg, et al., on Remifemin(R) black cohosh extract, published in Menopause: The Journal of The North American Menopause Society, suggest that suggest that Remifemin(R) black cohosh does not cause adverse effects on breast tissue, and, the data do not indicate any endometrial or general safety concerns during 6 months of treatment.
- Menopause Study Shows Remifemin(R) Black Cohosh Is Safer Than HRT
A new safety study by Hirschberg, et al., on Remifemin(R) black cohosh extract, published in Menopause: The Journal of The North American Menopause Society, suggest that suggest that Remifemin(R) black cohosh does not cause adverse effects on breast tissue, and, the data do not indicate any endometrial or general safety concerns during 6 months of treatment.
- Harvard Study: Soy Counteracts Metabolic Syndrome
Study published in the American Journal of Clinical Nutrition evaluated both soy protein and soy nut consumption among postmenopausal women living with metabolic syndrome, determining that soy protein and soy nuts each exhibited a beneficial effect on components of the syndrome, while soy nuts had the strongest impact.
- Harvard Study: Soy Counteracts Metabolic Syndrome
Study published in the American Journal of Clinical Nutrition evaluated both soy protein and soy nut consumption among postmenopausal women living with metabolic syndrome, determining that soy protein and soy nuts each exhibited a beneficial effect on components of the syndrome, while soy nuts had the strongest impact.
- Harvard Study: Soy Counteracts Metabolic Syndrome
Study published in the American Journal of Clinical Nutrition evaluated both soy protein and soy nut consumption among postmenopausal women living with metabolic syndrome, determining that soy protein and soy nuts each exhibited a beneficial effect on components of the syndrome, while soy nuts had the strongest impact.
- Harvard Study: Soy Counteracts Metabolic Syndrome
Study published in the American Journal of Clinical Nutrition evaluated both soy protein and soy nut consumption among postmenopausal women living with metabolic syndrome, determining that soy protein and soy nuts each exhibited a beneficial effect on components of the syndrome, while soy nuts had the strongest impact.
- Harvard Study: Soy Counteracts Metabolic Syndrome
Study published in the American Journal of Clinical Nutrition evaluated both soy protein and soy nut consumption among postmenopausal women living with metabolic syndrome, determining that soy protein and soy nuts each exhibited a beneficial effect on components of the syndrome, while soy nuts had the strongest impact.
- New Study Shows Positive Effect Of Linumlife On Breast Health
Preliminary results from recent human studies conducted at RMIT University in Australia show significant effects of flaxseed lignans intake on biomarkers of breast cancer risk in postmenopausal women.
- New Study Shows Positive Effect Of Linumlife On Breast Health
Preliminary results from recent human studies conducted at RMIT University in Australia show significant effects of flaxseed lignans intake on biomarkers of breast cancer risk in postmenopausal women.
- New Study Shows Positive Effect Of Linumlife On Breast Health
Preliminary results from recent human studies conducted at RMIT University in Australia show significant effects of flaxseed lignans intake on biomarkers of breast cancer risk in postmenopausal women.
- New Study Shows Positive Effect Of Linumlife On Breast Health
Preliminary results from recent human studies conducted at RMIT University in Australia show significant effects of flaxseed lignans intake on biomarkers of breast cancer risk in postmenopausal women.
- New Study Shows Positive Effect Of Linumlife On Breast Health
Preliminary results from recent human studies conducted at RMIT University in Australia show significant effects of flaxseed lignans intake on biomarkers of breast cancer risk in postmenopausal women.
- Calcium, Vitamin D Supplements May Help Prevent Weight Gain in Postmenopausal Women
A report featured in the May 14, 2007 edition of Archives of Internal Medicine evaluated 36,282 postmenopausal women ages 50 to 79 years who were enrolled in the Women's Health Initiative clinical trial, observing that those who took daily calcium and vitamin D supplements over a seven-year period weighed an average 0.28 pounds less, and were less likely to gain weight than women who received placebos.
- Calcium, Vitamin D Supplements May Help Prevent Weight Gain in Postmenopausal Women
A report featured in the May 14, 2007 edition of Archives of Internal Medicine evaluated 36,282 postmenopausal women ages 50 to 79 years who were enrolled in the Women's Health Initiative clinical trial, observing that those who took daily calcium and vitamin D supplements over a seven-year period weighed an average 0.28 pounds less, and were less likely to gain weight than women who received placebos.
- Calcium, Vitamin D Supplements May Help Prevent Weight Gain in Postmenopausal Women
A report featured in the May 14, 2007 edition of Archives of Internal Medicine evaluated 36,282 postmenopausal women ages 50 to 79 years who were enrolled in the Women's Health Initiative clinical trial, observing that those who took daily calcium and vitamin D supplements over a seven-year period weighed an average 0.28 pounds less, and were less likely to gain weight than women who received placebos.
- Calcium, Vitamin D Supplements May Help Prevent Weight Gain in Postmenopausal Women
A report featured in the May 14, 2007 edition of Archives of Internal Medicine evaluated 36,282 postmenopausal women ages 50 to 79 years who were enrolled in the Women's Health Initiative clinical trial, observing that those who took daily calcium and vitamin D supplements over a seven-year period weighed an average 0.28 pounds less, and were less likely to gain weight than women who received placebos.
- Calcium, Vitamin D Supplements May Help Prevent Weight Gain in Postmenopausal Women
A report featured in the May 14, 2007 edition of Archives of Internal Medicine evaluated 36,282 postmenopausal women ages 50 to 79 years who were enrolled in the Women's Health Initiative clinical trial, observing that those who took daily calcium and vitamin D supplements over a seven-year period weighed an average 0.28 pounds less, and were less likely to gain weight than women who received placebos.
- Calcium, Vitamin D Supplements May Help Prevent Weight Gain in Postmenopausal Women
A report featured in the May 14, 2007 edition of Archives of Internal Medicine evaluated 36,282 postmenopausal women ages 50 to 79 years who were enrolled in the Women's Health Initiative clinical trial, observing that those who took daily calcium and vitamin D supplements over a seven-year period weighed an average 0.28 pounds less, and were less likely to gain weight than women who received placebos.
- New Study: Pine Bark Reduces Perimenopausal Symptoms
Results of a randomized, double-blind, placebo controlled study conducted at Ham-Ming Hospital in Taiwan with 155 perimenopausal women, to be published in an upcoming edition of the Scandinavian Journal of Obstetrics and Gynaecology reveals that Pycnogenol® (pic-noj-en-all), pine bark extract from the French maritime pine tree, reduces “climacteric symptoms” such as hot flashes, depression, panic attacks, cholesterol and other common symptoms associated with women entering menopause transition.
- New Study: Pine Bark Reduces Perimenopausal Symptoms
Results of a randomized, double-blind, placebo controlled study conducted at Ham-Ming Hospital in Taiwan with 155 perimenopausal women, to be published in an upcoming edition of the Scandinavian Journal of Obstetrics and Gynaecology reveals that Pycnogenol® (pic-noj-en-all), pine bark extract from the French maritime pine tree, reduces “climacteric symptoms” such as hot flashes, depression, panic attacks, cholesterol and other common symptoms associated with women entering menopause transition.
- New Study: Pine Bark Reduces Perimenopausal Symptoms
Results of a randomized, double-blind, placebo controlled study conducted at Ham-Ming Hospital in Taiwan with 155 perimenopausal women, to be published in an upcoming edition of the Scandinavian Journal of Obstetrics and Gynaecology reveals that Pycnogenol® (pic-noj-en-all), pine bark extract from the French maritime pine tree, reduces “climacteric symptoms” such as hot flashes, depression, panic attacks, cholesterol and other common symptoms associated with women entering menopause transition.
- New Study Further Supports Safety of Promensil(R) as a Natural, Effective Way to Manage Mild-to-Moderate Menopausal Symptoms
Results of a large, three-year study -- published last month in the journal Menopause International reinforcing the safety of Promensil(R) red clover isoflavone supplement for managing hot flashes and other menopausal symptoms.
- New Study Further Supports Safety of Promensil(R) as a Natural, Effective Way to Manage Mild-to-Moderate Menopausal Symptoms
Results of a large, three-year study -- published last month in the journal Menopause International reinforcing the safety of Promensil(R) red clover isoflavone supplement for managing hot flashes and other menopausal symptoms.
- New Study Further Supports Safety of Promensil(R) as a Natural, Effective Way to Manage Mild-to-Moderate Menopausal Symptoms
Results of a large, three-year study -- published last month in the journal Menopause International reinforcing the safety of Promensil(R) red clover isoflavone supplement for managing hot flashes and other menopausal symptoms.
- Next Pharmaceuticals Announces a New Clinical Study Demonstrating Relora® Significantly Relieves Short-Term Anxiety in Healthy Women
Next Pharmaceuticals has announced the results of a six-week, double-blind, placebo-controlled clinical study, published in Nutrition Journal, on Relora conducted on healthy women between the ages of 20 and 50
- Next Pharmaceuticals Announces a New Clinical Study Demonstrating Relora® Significantly Relieves Short-Term Anxiety in Healthy Women
Next Pharmaceuticals has announced the results of a six-week, double-blind, placebo-controlled clinical study, published in Nutrition Journal, on Relora conducted on healthy women between the ages of 20 and 50
- Next Pharmaceuticals Announces a New Clinical Study Demonstrating Relora® Significantly Relieves Short-Term Anxiety in Healthy Women
Next Pharmaceuticals has announced the results of a six-week, double-blind, placebo-controlled clinical study, published in Nutrition Journal, on Relora conducted on healthy women between the ages of 20 and 50
- New Study Suggests Pine Bark Reduces Menstrual Pain
A multi-center field study, published in the Journal of Reproductive Medicine, suggests that women with dysmenorrhea who supplemented with Pycnogenol experienced less pain and required less pain medications during menstruation.
- New Study Suggests Pine Bark Reduces Menstrual Pain
A multi-center field study, published in the Journal of Reproductive Medicine, suggests that women with dysmenorrhea who supplemented with Pycnogenol experienced less pain and required less pain medications during menstruation.
- New Study Suggests Pine Bark Reduces Menstrual Pain
A multi-center field study, published in the Journal of Reproductive Medicine, suggests that women with dysmenorrhea who supplemented with Pycnogenol experienced less pain and required less pain medications during menstruation.
- Scientific Event Puts Spotlight on the Role of Nutrition in Women's Health, Early Childhood and Adolescence
Scientists will focus on the role of food supplements in women’s health, early childhood and adolescence at an upcoming scientific conference in London organised by the UK Council for Responsible Nutrition (CRN). The event will take place on 28 April 2009 at the Royal College of Physicians in London.
- Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award
The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology.
- Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award
The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology.
- Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award
The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- NPI Daily - Top of The News for Nov. 20, 2009 - FDA Issues 22 Warning Letters to Website Operators
Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award; Synergy Flavors Invests in Sensory Flavor Profiling Research; FDA Issues 22 Warning Letters to Website Operators; Nordic Naturals Ultimate Omega™ First Fish Oil to Participate in NFL/NFLPA Sports Nutrition Label Certification Program; BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates; New Organic Berry Whole Food Energy Bar from Amazing Grass Delivers Whole Food Nutrition; Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
- NPI Daily - Top of The News for Nov. 20, 2009 - FDA Issues 22 Warning Letters to Website Operators
Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award; Synergy Flavors Invests in Sensory Flavor Profiling Research; FDA Issues 22 Warning Letters to Website Operators; Nordic Naturals Ultimate Omega™ First Fish Oil to Participate in NFL/NFLPA Sports Nutrition Label Certification Program; BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates; New Organic Berry Whole Food Energy Bar from Amazing Grass Delivers Whole Food Nutrition; Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
- Heart Health Alert: Niacin May Reverse Hardening of the Arteries
- Heart Health Alert: Niacin May Reverse Hardening of the Arteries
- Heart Health Alert: Niacin May Reverse Hardening of the Arteries
- Heart Health Alert: Niacin May Reverse Hardening of the Arteries
- Spotlight on Savory Side Dishes
- Spotlight on Savory Side Dishes
- Spotlight on Savory Side Dishes
- Another Reason to Choose Healthy Lifestyle Habits
- Another Reason to Choose Healthy Lifestyle Habits
|
CINCINNATI, July 11, 2006 /PRNewswire via COMTEX/ -- A new study published in the July issue of the American Journal of Gastroenterology found that Bifantis (Bifidobacterium infantis 35624) may help relieve many of the symptoms associated with irritable bowel syndrome (IBS) in women, including diarrhea and constipation(1).
IBS, the most common functional bowel disorder diagnosed by physicians and gastroenterologists, is estimated to affect up to one in five Americans(2). Bifantis(TM) is the first and only probiotic, or "good" bacteria, that has been clinically proven to help manage the full range of symptoms of IBS in a large scale, placebo-controlled clinical trial. The study was sponsored by P&G Health Sciences Institute.
"We are pleased and excited with the results of this study, as it represents an advance in the treatment of IBS which can cause such embarrassing symptoms, often on a daily basis," said Dr. Peter Whorwell, Professor of Medicine and Gastroenterology at the University of Manchester (UK) and lead author of the study.
About the Study
In a randomized, double-blind, placebo-controlled, dose-ranging study, 362 women between 18 and 65 years of age who had been diagnosed with IBS (per Rome II criteria) received placebo or freeze-dried, encapsulated Bifantis once daily for four weeks(1). Throughout the study, patients daily recorded how they felt related to abdominal pain/discomfort, bloating/distension, sense of incomplete evacuation, straining at stool, urgency of bowel movement, passage of gas and mucus and bowel habit satisfaction(1). Patients also recorded their global assessment of relief for both abdominal pain/discomfort and their IBS symptoms(1).
At the end of the four week study, Bifantis was observed to be significantly superior to placebo for abdominal pain as well as bloating, bowel dysfunction, incomplete evacuation, straining and the passage of gas(1). Overall, improvements in symptoms experienced were highest in the 1x10(8) cfu dose group(1). Patients' global symptom assessment was superior to placebo by more than 20 percent. No significant adverse events were recorded(1).
About Bifantis
Bifantis is the trademarked name for the probiotic strain Bifidobacterium infantis 35624(3). These normal, friendly bacteria play an important role in basic digestion, proper metabolism and overall well-being(3). Bifantis works within the digestive system to restore intestinal balance and maintain normal digestive health(3). Bifantis is a calorie- and lactose-free natural dietary ingredient that is similar to the active cultures found in some yogurts and fermented milks(3).
Bifantis may be especially helpful for people who experience one or more of the symptoms commonly associated with IBS, including diarrhea, constipation, bloating, gas, urgency and abdominal discomfort(3).
For additional information on Bifantis, visit http://www.bifantis.com or http://www.pghsi.com .
About Irritable Bowel Syndrome (IBS)
Irritable bowel syndrome is the most common functional bowel disorder, and it is characterized by a range of symptoms, including abdominal pain and discomfort, bloating and altered bowel function (constipation and/or diarrhea)(2).
IBS, most often diagnosed by a primary care physician or gastroenterologist, is second only to the common cold as a leading cause of workplace absenteeism in the United States(2). Significant morbidity is associated with IBS, as patients suffering from IBS-related symptoms endure a decreased quality of life as they are prevented from participating in activities they would normally enjoy(2). The impact on quality of life has been estimated to be greater than that of diabetes and similar to that of clinical depression(2).
The current goal of therapy is management and reduction in the frequency and severity of episodes or symptoms(2). The management of IBS currently ranges from dietary (increasing fiber and reducing dairy products) and behavioral changes (restricting diet and slowly adding in new foods) to medications (over-the-counter and prescription)(2).
About Probiotics
The word "probiotic" means "for life." Probiotics are beneficial bacteria, or "good, friendly" bacteria that can help strengthen the body's natural defenses, and help restore the appropriate balance of healthy bacteria. Research still is being conducted on how probiotic cultures may influence a wide-range of health conditions, however, it has been established through controlled scientific investigations that probiotics ingested in certain numbers exert health affects beyond inherent basic nutrition(2,3).
About P&G Health Sciences Institute
The P&G Health Sciences Institute is a conglomerate of P&G research expertise and capabilities including state of the art research facilities dedicated to identifying, developing, and using leading health care technologies in the development of effective products for both the developing and developed world. Procter & Gamble has a long history of scientific research both internally and through collaboration with external partners in the areas of health, hygiene, and nutrition, dating back more than 50 years. Please visit http://www.pghsi.com for more information on the P&G Health Sciences Institute as well as http://www.pg.com for the latest news and in-depth information about P&G and its brands.
(1) Efficacy of an Encapsulated Probiotic Bifidobacterium Infantis 35624
in Women with Irritable Bowel Syndrome, published in the American
Journal of Gastroenterology, July 2006
(2) http://www.pghsi.com/gastrointestinal/probiotics.html , accessed on
6.16.06
(3) http://www.usprobiotics.org/basics/ , probiotics and dairy products
section, accessed on 6.16.06 |